OVERVIEW

WP 3 – HIV

THIV remains a public health menace in West Africa despite its relatively low prevalence compared to in East and Southern Africa [12]. According to the UNAIDS Global epidemic update and health sector progress towards universal access report 2011, none of the West African countries was among those who achieved 80% coverage of HIV treatment; only Benin was cited amongst those with 60% coverage and no West African country had a decline of more than 39% of number of children with new infections between 2009-2011. In Guinea Bissau the number of new infections among children increased. Nigeria was listed amongst the countries with less than 25% PMTC coverage despite being just behind South Africa in HIV burden globally. Furthermore, no PrEP trial and limited implementation of PrEP and TASP has been carried out in at-risk populations such as MSM, sero-discordants, or sex-workers cohorts in the region. To improve the situation, WANETAM- will carry out the following work package activities that will strengthen capacities in HIV surveillance for drug adherence and resistance; diagnosis and feasible viral load monitoring, including early paediatric diagnosis.

Objectives

  • Establish a unified cohort database of at-risk populations and facilitate the sharing of data including ART-acquired and ART transmitted resistance  across participating sites
  • Validate and roll out Viral load assays for both HIV 1 and HIV 2
  • Facilitate a platform and train sites on HIV drug resistance testing
  • Strengthen South-South and North-South Collaboration Complete?

Activities

  • To develop the West African unified HIV cohort database
    • HIV-WP – Activity 1 – Enriching unified cohort database of at-risk populations and sharing data resource
    • HIV-WP- Activity 2 – Develop and sharing data on   ART-acquired and ART-transmitted resistance in the treatment programs.

Validate and roll out Viral load (VL) assays for HIV-1 and HIV-2

  • HIV-WP–Activity 3 – Validation of the In-house HIV-1/HIV-2 RT-PCR VL assay and Viral load POCs evaluation
  • HIV-WP-Activity 4– Phasedimplementation of VL assays

HIV specific training on drug resistance tests and VL/paediatric HIV diagnosis

  • HIV-WP-Activity 5 Training attachment for drug resistance test
  • HIV-WP-Activity 6 – Training workshop on VL and early infant diagnosis (EID)

 

Phone

(+221) 33 872 26 64

Location

Arrondissement 4, Rue 2 D1 POLE URBAIN DE DIAMNIADO BP 7325, Dakar

Email

contact@wanetam.org

Opening Hours

Mon. – Fri.
08:00 am- 16:30 pm

Copyright 2020 @wanetam | All right reserved.